HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Gotoh Selected Research

Antigens

2/2014Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan.
3/2011Efficacy of epinastine hydrochloride for antigen-provoked nasal symptoms in subjects with orchard grass pollinosis.
12/2010Clinical pharmacology study of the corticosteroid nasal spray dexamethasone cipecilate (NS-126): examination of the durability of efficacy in the nasal induction test.
12/2008Oral administration of heat-killed Lactobacillus gasseri OLL2809 reduces cedar pollen antigen-induced peritoneal eosinophilia in Mice.
9/2006Inhibition of the antigen provoked nasal reaction by second-generation antihistamines in patients with Japanese cedar pollinosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Gotoh Research Topics

Disease

20Seasonal Allergic Rhinitis (Hay Fever)
05/2023 - 06/2004
16Allergic Rhinitis
04/2023 - 02/2005
4Hypersensitivity (Allergy)
04/2023 - 02/2005
3Asthma (Bronchial Asthma)
04/2023 - 01/2012
3Perennial Allergic Rhinitis
06/2017 - 12/2010
3Sneezing
12/2011 - 09/2006
2Rhinitis
05/2023 - 10/2019
2Anaphylaxis (Anaphylactic Shock)
02/2014 - 06/2009
2Nasal Obstruction
11/2012 - 01/2012
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
04/2023
1Atopic Dermatitis (Atopic Eczema)
04/2023
1Drug Hypersensitivity (Drug Allergy)
04/2023
1Food Hypersensitivity (Food Allergy)
04/2023
1Drug-Related Side Effects and Adverse Reactions
01/2020
1Conjunctivitis
10/2019
1Fatigue
12/2013
1Rhinorrhea
12/2011
1Eosinophilia
12/2008

Drug/Important Bio-Agent (IBA)

5AllergensIBA
05/2023 - 06/2009
5TabletsIBA
05/2023 - 10/2019
5AntigensIBA
02/2014 - 09/2006
4pranlukastIBA
11/2012 - 12/2011
3Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2012 - 12/2011
2Histamine Antagonists (Antihistamines)IBA
01/2023 - 02/2005
2Immunoglobulin E (IgE)IBA
01/2020 - 09/2009
2Anti-Allergic Agents (Antiallergic Agents)IBA
09/2018 - 06/2004
2bilastineIBA
06/2017 - 01/2017
2epinastineFDA Link
03/2011 - 09/2006
2fexofenadine (Allegra)FDA LinkGeneric
09/2006 - 02/2005
1MetalsIBA
04/2023
1amsonic acid (DAS)IBA
04/2023
1anti-IgE antibodiesIBA
01/2023
1Immunoglobulin G (IgG)IBA
01/2020
1Messenger RNA (mRNA)IBA
09/2018
1CytokinesIBA
01/2018
1Therapeutic UsesIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2013
1Lactalbumin (alpha-Lactalbumin)IBA
12/2013
1Oxygen (Dioxygen)IBA
12/2013
1Eosinophil Cationic ProteinIBA
11/2012
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
11/2012
1montelukast (Singulair)FDA Link
01/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2010
1Dust (House Dust)FDA Link
12/2010
1bepotastineFDA Link
03/2009
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
09/2006
1SteroidsIBA
06/2004
1Ophthalmic Solutions (Eye Drops)IBA
06/2004

Therapy/Procedure

3Immunotherapy
01/2022 - 06/2009
3Oral Administration
01/2012 - 12/2008
2Drug Therapy (Chemotherapy)
01/2023 - 06/2009